Dynavax Technologies: Time To Refocus On Former Cash Cow CpG1018
Dynavax should take a leaf from its vaccine maker peer, Novavax, and work to monetize its CpG1018 adjuvant. Learn more about ...
Hosted on MSN22h
Novavax (NVAX) Rises But Trails Market: What Investors Should Know
Novavax (NVAX) closed the most recent trading day at $8.45, moving +0.24% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 0.72%. Meanwhile, the Dow ...
Vaccine, Packaged Food Stocks Fall as Kennedy Moves Closer to Health Secretary Job
Kennedy, who has faced opposition from health groups and Democrats, has long sown doubts about the safety and efficacy of ...
Zacks.com on MSN1d
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.